Melanoma survivorship: Research opportunities

Journal of Cancer Survivorship

Volumn 1, Issue 1, 2007, Pages 87-97

  Oliveria, Susan A ^a   Hay, Jennifer L ^a   Geller, Alan C ^b,c   Heneghan, Maureen K ^a   McCabe, Mary S ^a   Halpern, Allan C ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Melanoma; Prevention; Research opportunities; Surveillance; Survivorship

Indexed keywords

ADULT; ARTICLE; CANCER REGISTRY; COST OF ILLNESS; EVIDENCE BASED MEDICINE; HUMAN; INCIDENCE; MELANOMA; MIDDLE AGED; MORTALITY; QUALITY OF LIFE; RESEARCH; SKIN TUMOR; SURVIVOR;

ADULT; COST OF ILLNESS; EVIDENCE-BASED MEDICINE; HUMANS; INCIDENCE; MELANOMA; MIDDLE AGED; QUALITY OF LIFE; RESEARCH; SEER PROGRAM; SKIN NEOPLASMS; SURVIVORS;

EID: 34047199409     PISSN: 19322259     EISSN: 19322267     Source Type: Journal    
DOI: 10.1007/s11764-007-0009-y     Document Type: Article

References (113)

1. Aitchison, T. C., Sirel, J. M., Watt, D. C., & MacKie, R. M. (1995). Prognostic trees to aid prognosis in patients with cutaneous malignant melanoma. Scottish Melanoma Group. British Medical Journal, 311(7019), 1536-1539; discussion 1539-1541.
2. Aitken, J. F., Green, A. C., MacLennan, R., Youl, P., & Martin, N. G. (1996). The Queensland Familial Melanoma Project: Study design and characteristics of participants. Melanoma Research, 6(2), 155-165.
3. American Cancer Society (2005). American cancer society: Cancer facts & figures 2005. Atlanta, GA: American Cancer Society.
4. Armstrong, B. K., & Kricker, A. (1993). How much melanoma is caused by sun exposure? Melanoma Research, 3(6), 395-401.
5. Autier, P., & Dore. J. F. (1998). Influence of sun exposures during childhood and during adulthood on melanoma risk. EPIMEL and EORTC Melanoma Cooperative Group. European Organisation for Research and Treatment of Cancer. International Journal of Cancer, 77(4), 533-537.
6. Aziz, N. M. (2002). Cancer survivorship research: Challenge and opportunity. Journal of Nutrition, 132(11 Suppl), 3494S-3503S.
7. Azzarello, L. M., Dessureault, S., & Jacobsen, P. B. (2006). Sun-protective behavior among individuals with a family history of melanoma. Cancer Epidemiology Biomarkers & Prevention, 15 (1), 142-145.
8. Berndt. E., & Crown, W. (2002). Labor force activity in cancer patients with anemia. Quality of Life in Oncology 5, 10-13.
9. Berwick, M., Armstrong, B. K., Ben-Porat, L., Fine, J., Kricker, A., Eberle, C., et al. (2005). Sun exposure and mortality from melanoma. Journal of the National Cancer Institute, 97(3), 195-199.
10. Berwick, M., Begg, C. B., Fine, J. A., Roush, G. C., & Barnhill, R. L. (1996). Screening for cutaneous melanoma by skin self-examination. Journal of the National Cancer Institute, 88(1), 17-23.
11. Boyle, D. A. (2003). Psychological adjustment to the melanoma experience. Seminars in Oncology Nursing, 19(1), 70-77.
12. Breslow, A. (1970). Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Annals of Surgery, 172(5), 902-908.
13. Brown, J. E., King, M. T., Butow, P. N., Dunn, S. M., & Coates, A. S. (2000). Patterns over time in quality of life, coping and psychological adjustment in late stage melanoma patients: An application of multilevel models. Quality of Life Research, 9(1), 75-85.
14. Brown, M. L., Riley, G. F., Schussler, N., & Etzioni, R. D. Health care costs related to cancer treatment from SEER-Medicare data. Medical Care, 40(Suppl 8), 104-117.
15. Butow, P. N., Coates, A. S., & Dunn, S. M. (1999). Psychosocial predictors of survival in metastatic melanoma. Journal of Clinical Oncology, 17(1), 2256-2263.
16. Cancer survivorship - United States, 1971-2001. (2004). Morbidity and Mortality Weekly Report, 55(24), 526-529.
17. Carmel, S., Shani, E., & Rosenberg, L. (1994). The role of age and an expanded Health Belief Model in predicting skin cancer protective behavior. Health Education Research, 9(4), 433-447.
18. Carmichael, V. E., & Wilson, K. S. (1992). Primary cutaneous malignant melanoma: Experience of the British Columbia Cancer Agency from 1972 to 1981. Canadian Journal of Surgery, 35(6), 589-597.
19. Chang, S., Longm, S. R., Kutikova, L., Bowman, L., Finley, D., Crown, W. H., et al. (2004). Estimating the cost of cancer: Results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000. Journal of Clinical Oncology, 22(17), 3524-3530.
20. Cohn-Cedermark, G., Mansson-Brahme, E., Rutqvist, L. E., Larsson, O., Singnomklao, T., & Ringborg, U. (1999). Metastatic patterns, clinical outcome, and malignant phenotype in malignant cutaneous melanoma. Acta Oncoloâgica, 38(5), 549-557.
21. Coups, E. J, & Ostroff, J. S. (2005). A population-based estimate of the prevalence of behavioral risk factors among adult cancer survivors and noncancer controls. Preventive Medicine, 40(6), 702-711.
22. Cristofolini, M., Zumiani, G., Boi, S., & Piscioli, F. (1986). Community detection of early melanoma, Lancet, 1(8473), 156.
23. Demark-Wahnefried, W., Aziz, N. M., Rowland, J. H., & Pinto, B. M. (2005). Riding the crest of the teachable moment: Promoting long-term health after the diagnosis of cancer. Journal of Clinical Oncology, 23(24), 5814-5830.
24. Dennis, L. K., White, E., & Lee, J. A. (1993). Recent cohort trends in malignant melanoma by anatomic site in the United States. Cancer Causes & Control, 4(2), 93-100.
25. Dicker, T. J., Kavanagh, G. M., Herd, R. M., Ahmad, T., McLaren, K. M., Chetty, U., et al. (1999). A rational approach to melanoma follow-up in patients with primary cutaneous melanoma. Scottish Melanoma Group. British Journal of Dermatology, 140(2), 249-254,
26. Diepgen, T. L., & Mahler, V. (2002). The epidemiology of skin cancer. British Journal of Dermatology, 146(Suppl 61), 1-6.
27. DiFronzo, L. A., Wanek, L. A., Elashoff, R., & Morton, D. L. (1999). Increased incidence of second primary melanoma in patients with a previous cutaneous melanoma. Annals of Surgical Oncology, 6(7), 705-711.
28. Duggleby, W. F., Stoll, H., Priore, R. L., Greenwald, P., & Graham, S. (1981). A genetic analysis of melanoma-polygenic inheritance as a threshold trait, American Journal of Epidemiology, 114(1), 63-72.
29. Edman, R. L., & Klaus, S. N. (2000). Is routine screening for melanoma a benign practice? Journal of the American Medical Association, 284(7), 883-886.
30. English, D. R., Milne, E., & Simpson, J. A. (2006). Ultraviolet radiation at places of residence and the development of melanocytic nevi in children (Australia). Cancer Causes & Control, 17(1), 103-107.
31. Fawzy, F. I., Fawzy, N. W., Hyun, C. S., Elashoff, R., Guthrie, D., Fahey, J. L., et al. (1993). Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Archives of General Psychiatry, 50(9), 681-689.
32. Fillenbaum, G. G., Pieper, C. F., Cohen, H. J., Cornoni-Huntley, J. C., & Guralnik, J. M. (2000). Comorbidity of five chronic health conditions in elderly community residents: Determinants and impact on mortality. Journal of Gerontology: Medical Sciences, 55A, M84-M89.
33. Fireman, B. H., Quesenberry, C. P., Somkin, C. P., Jacobson, A. S., Baer, D., West, D., et al. (1997). Cost of care for cancer in a health maintenance organization. Health Care Financing Review, 18(4), 51-76.
34. Freiman, A., Yu, J., Loutfi, A., & Wang, B. (2004). Impact of melanoma diagnosis on sun-awareness and protection: Efficacy of education campaigns in a high-risk population. Journal of Cutaneous Medicine and Surgery, 8(5), 303-309.
35. Friedman, R. J., Rigel, D. S., Silverman, M. K., Kopf, A. W., & Vossaert, K. A. (1991). Malignant melanoma in the 1990s: The continued importance of early detection and the role of physician examination and self-examination of the skin. CA-A Cancer Journal for Clinicians, 41(4), 201-226.
36. Friedman, L. C., Webb, J. A., Bruce, S., Weinberg, A. D., & Cooper, H. P. (1995). Skin cancer prevention and early detection intentions and behavior. American Journal of Preventive Medicine, 11(1), 59-65.
37. Garbe, C. (2002). A rational approach to the follow-up of melanoma patients. Recent Results in Cancer Research, 160, 205-215.
38. Garbe, C., & Orfanos, C. E. (1992). Epidemiology of malignant melanoma in central Europe: Risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society. Pigment Cell Research, (Suppl 2), 285-294.
39. Garman, K. S., Pieper, C. F., Seo, P., & Cohen, H. J. (2003). Function in elderly cancer survivors depends on comorbidities. Journal of Gerontology, 58A (11), 119-1124.
40. Geller, A. C., Emmons, K. M., Brooks, D. R., Powers, C. Zhang, Z., Koh, H. K., et al. (2006). A randomized trial to improve early detection and prevention practices among siblings of melanoma patients. Cancer, 107(4), 806-814.
41. Geller, A. C., Koh, H. K., Miller, D. R., & Lew, R. A. (1992). Practices and beliefs concerning screening family members of patients with melanoma. Results of a survey of New England dermatologists. Journal of the American Academy of Dermatology, 26(3 Pt 2), 419-422.
42. Geller, A. C., Miller, D. R., Annas, G. D., Demierre, M. F., Gilchrest, B. A., & Koh, H. K. (2002). Melanoma incidence and mortality among US whites, 1969-1999. Journal of the American Medical Association, 288(14), 1719-1720.
43. Gilchrest, B. A., Eller, M. S., Geller, A. C., & Yaar, M. (1999). The pathogenesis of melanoma induced by ultraviolet radiation. New England Journal of Medicine, 340( 17), 1341-1348.
44. Gloeckler Ries, L. A., Reichman, M. E., Lewis, D. R., Hankey, B. F., & Edwards, B. K. (2003). Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program. Oncologist, 8(6), 541-552.
45. Goggins, W. B., Finkelstein, D. M., & Tsao, H. (2001). Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma. Cancer, 91(4), 874-880.
46. Goldsmith, L. A., Koh, H. K., Bewerse, B. A., Reilley, B., Wyatt, S. W., Bergfeld, W. F., et al. (1996). Full proceedings from the National Conference to Develop a National Skin Cancer Agenda. In American Academy of Dermatology and Centers for Disease Control and Prevention, Washington, D.C., April 8-10, 1995. Journal of the American Academy of Dermatology, 35(5 Pt 1), 748-756.
47. Gotay, C. C., & Muraoka, M. Y. (1998). Quality of life in long-term survivors of adult-onset cancers. Journal of the National Cancer Institute, 90(9), 656-667.
48. Greer, S., Morris, T., Pettingale, K. W., & Haybittle, J. L. (1990). Psychological response to breast cancer and 15-year outcome. Lancet, 335(8680), 49-50.
49. Hall, H. I., May, D. S., Lew, R. A., Koh, H. K., & Nadel, M. (1997). Sun protection behaviors of the U.S. white population. Preventive Medicine, 26(4), 401-407.
50. Hay, J., Ostroff, J., Martin, A., Serle, N., Soma, S., Mujumdar, U., et al. (2005). Skin cancer risk discussions in melanoma-affected families. Journal of Cancer Education, 20(4), 240-246.
51. Hewitt, M., Breen, N., & Devesa, S. (1999). Cancer prevalence and survivorship issues: Analyses of the 1992 National Health Interview Survey. Journal of the National Cancer Institute, 91 (17), 1480-1486.
52. Hewitt, M., Rowland, J. H., & Yancik, R. (2003). Cancer survivors in the United States: Age, health, and disability. Journals of Gerontology Series A, Biological Sciences and Medical Sciences, 58(1), 82-91.
53. Hillner, B. E., Kirkwood, J. M., & Agarwala, S. S. (2001). Burden of illness associated with metastatic melanoma: An audit of 100 consecutive referral center cases. Cancer, 91(9), 1814-1821.
54. Honda, K., & Neugut, A. I. (2004). Associations between perceived cancer risk and established factors in a national community sample. Cancer Detection and Prevention, 28, 1-7.
55. Howe, H. L., Wingo, P. A., Thun, M. J., Ries, L. A., Rosenberg, H. M., Feigal, E. G., et al. (2001). Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. Journal of the National Cancer Institute, .93(11), 824-842.
56. Huang, X., Soong, S., McCarthy, W. H., Urist, M. M., & Balch, C. M. (1997). Classification of localized melanoma by the exponential survival trees method. Cancer, 79(6), 1122-1128.
57. Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., et al. (2005). Cancer statistics, 2005. CA-A Cancer Journal for Clinicians, 55(1), 10-30.
58. Keesling, B., & Friedman, H. S. (1987). Psychosocial factors in sunbathing and sunscreen use. Health Psychology, 6(5), 477-493.
59. Khayat, D., Rixe, O., Martin, G., Soubrane, C., Banzet, M., Bazex, J. A., et al. (2003). Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1mm thick). Cancer, .97(8), 1941-1946.
60. Koh, H. K. (1991). Cutaneous melanoma. New England Journal of Medicine, 325(3), 171-182.
61. Koh, H. K., Geller, A. C, & Lew, R. A. (1999). Melanoma. In B. S. Kramer, J. K. Gohagen, & P. C. Prorok (Eds.), Cancer screening: Theory and practice (pp. 379-408). New York: Marcel Dekker.
62. Koh, H. K., Lew, R. A., & Prout, M. N. (1989). Screening for melanoma/skin cancer: Theoretic and practical considerations. Journal of the American Academy of Dermatology, 20(2 Pt 1), 159-172.
63. Koh, H. K., Miller, D. R., Geller, A. C., Clapp, R. W., Mercer, M. B., & Lew, R. A. (1992). Who discovers melanoma? Patterns from a population-based survey. Journal of the American Academy of Dermatology, 26(6), 914-919.
64. Kopf, A. W., Rigel, D. S., & Friedman, R. J. (1982). The rising incidence and mortality rate of malignant melanoma. Journal of Dermatologic Surgery and Oncology, 8(9), 760-761.
65. Kornblith, A. B. (1998). Psychosocial adaptation of cancer survivors. In J. C. Holland (Ed.), New York: Oxford University Press.
66. Leman, J. A., & Mac Kie, R. M. (2003). Late (>10 years) recurrence of melanoma: The Scottish experience. British Journal of Dermatology, 148(2), 372-373.
67. Leventhal, H., Kelly, K., & Leventhal, E. A. (1999). Population risk, actual risk, perceived risk, and cancer control: A discussion. Journal of the National Cancer Institute. Monographs, 25, 81-85.
68. Lipkus, I. M., Rimer, B. K., & Strigo, T. S. (1996). Relationships among objective and subjective risk for breast cancer and mammography stages of change. Cancer Epidemiology Biomarkers and Preventions, 5(12), 1005-1011.
69. MacKie, R. M., & Hole, D. (1992). Audit of public education campaign to encourage earlier detection of malignant melanoma. British Medical Journal, 304(6833), 1012-1015.
70. Manne, S., Fasanella, N., Connors, J., Floyd, B., Wang, H., & Lessin, S. (2004). Sun protection and skin surveillance practices among relatives of patients with malignant melanoma: Prevalence and predictors. Preventive Medicine, 39(1), 36-47.
71. Manne, S., & Lessin, S. (2006). Prevalence and correlates of sun protection and skin self-examination practices among cutaneous malignant melanoma survivors. Journal of Behavioral Medicine, 29(5), 419-434.
72. Margolis, D. J., Halpern, A. C., Rebbeck, T., Schlichter, L., Barnhill, R. L., Fine, J., et al. (1998). Validation of a melanoma prognostic model. Archives of Dermatology, 134(12), 1597-1601.
73. Masback, A., Westerdahl, J., Ingvar, C., Olsson, H., & Jonsson, N. (1997). Cutaneous malignant melanoma in southern Sweden 1965, 1975, and 1985. Prognostic factors and histologic correlations. Cancer, 79(2), 275-283.
74. McBride, C. M., Emmons, K. M., & Lipkus, I. M. (2003). Understanding the potential of teachable moments: The case of smoking cessation. Health Education Research, 18(2), 156-170.
75. McKenna, D. B., Stockton, D., Brewster, D. H., & Doherty, V. R. (2003). Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: A population-based retrospective cohort study in Scotland. British Journal of Cancer, 88(1), 74-78.
76. McPherson, M., Elwood, M., English, D. R., Baade, P. D., Youl, P. H., & Aitken, J. F. (2006). Presentation and detection of invasive melanoma in a high-risk population. Journal of the American Academy of Dermatology, 54(5), 783-792.
77. Miller, D. R., Geller, A. C., Wyatt, S. W., Halpern, A., Howell, J. B., Cockerell, C., et al. (1996). Melanoma awareness and self-examination practices: Results of a United States survey. Journal of the American Academy of Dermatology, 34(6), 962-970.
78. Miller, D. L., & Weinstock, M. A. (1994). Nonmelanoma skin cancer in the United States: Incidence. Journal of the American Academy of Dermatology, 30(5 Pt 1), 774-778.
79. Molassiotis, A., Van Den Akker, O. B., Milligan, D. W., & Goldman, J. M. (1997). Symptom distress, coping style and biological variables as predictors of survival after bone marrow transplantation. Journal of Psychosomatic Research, 42(3), 275-285.
80. National Cancer Institute (2002). US estimated complete prevalence counts on 1/1/2002 first malignant cancer only by cancer site, sex, and race. CanQuest Hosting Service, 2002. (Ed.). Available at http://canques.seer.cancer.gov.
81. NIH Consensus conference (1992). Diagnosis and treatment of early melanoma. Journal of the American Medical Association, 268(10), 1314-1319.
82. Ostroff, J., Garland, J., Moadel, A., Fleshner, N., Hay, J., Cramer, L., et al. (2000). Cigarette smoking patterns in patients after treatment of bladder cancer. Journal of Cancer Education, 15(2), 86-90.
83. Pakilit, A. T., Kahn, B. A., Petersen, L., Abraham, L. S., Greendale, G. A., & Ganz, P. A. (2001). Making effective use of tumor registries for cancer survivorship research. Cancer, 92(5), 1305-1314.
84. Pehamberger, H., Binder, M., Knollmayer, S., & Wolff, K. (1993). Immediate effects of a public education campaign on prognostic features of melanoma. Journal of the American Academy of Dermatology, 29(1), 106-109.
85. Pinto, B. M., Eakin, E., & Maruyama, N. C. (2000). Health behavior changes after a cancer diagnosis: What do we know and where do we go from here? Annals of Behavioral Medicine, 22(1), 38-52.
86. Ponder, M., Lee, J., Green, J., & Richards, M. (1996). Family history and perceived vulnerability to some common diseases: A study of young people and their parents. Journal of Medical Genetics, 33(6), 485-492.
87. Rhee, J. S., Matthews, B. A., Neuburg, M., Smith, T. L., Burzynski, M., & Nattinger, A. B. (2004). Quality of life and sun-protective behavior in patients with skin cancer. Archives of Otolaryngology, Head & Neck Surgery, 130(2), 141-146.
88. Rhodes, A. R. (1995). Public education and cancer of the skin. What do people need to know about melanoma and non-melanoma skin cancer? Cancer, 75(Suppl 2), 613-636.
89. Rhodes, A. R., Weinstock, M. A., Fitzpatrick, T. B., Mihm, M. C., Jr., & Sober, A. J. (1987). Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals. Journal of the American Medical Association, 258 (21), 3146-3154.
90. Robison, L. L. (2004). Cancer survivorship: Unique opportunities for research. Cancer Epidemiology Biomarkers & Preventions, 13(7), 1093.
91. Robinson, J. K., Rigel, D. S., & Amonette, R. A. (1998). What promotes skin self-examination? Journal of the American Academy of Dermatology, 38(5 Pt 1), 752-757.
92. Rogentine, G. N., Jr., van Kammen, D. P., Fox, B. H., Docherty, J. P., Rosenblatt, J. E., Boyd, S. C., et al. (1979). Psychological factors in the prognosis of malignant melanoma: A prospective study. Psychosomatic Medicine, 41(8), 647-655.
93. Roush, G. C., McKay, L., & Holford, T. R. (1992). A reversal in the long-term increase in deaths attributable to malignant melanoma. Cancer, 69(7), 1714-1720.
94. Sahin, S., Rao, B., Kopf, A. W., Lee, E., Rigel, D. S., Nossa, R., et al. (1997). Predicting ten-year survival of patients with primary cutaneous melanoma: Corroboration of a prognostic model. Cancer, 80(8), 1426-1431.
95. Salasche, S. J. (2000). Epidemiology of actinic keratoses and squamous cell carcinoma. Journal of the American Academy of Dermatology, 42(1 Pt 2), 4-7.
96. Schag, C. A. C., Ganz, P. A., Wing, D. S., Sim, M. S., & Lee, S. S. (1994). Quality of life in adult survivors of lung, colon and prostate cancer. Quality of Life Research, 3(2), 127-141.
97. Schuchter, L., Schultz, D. J., Synnestvedt, M., Trock, B. J., Guerry, D., Elder, D. E., et al. (1996). A prognostic model for predicting 10-year survival in patients with primary melanoma. The Pigmented Lesion Group. Annals of Internal Medicine, 125 (5), 369-375.
98. Scotto, J., Pitcher, H., & Lee, J. A. (1991). Indications of future decreasing trends in skin-melanoma mortality among whites in the United States. International Journal of Cancer, 49(4), 490-497.
99. Senior, V., Marteau, T. M., & Weinman, J. (2000). Impact of genetic testing on causal models of heart disease and arthritis: An analogue study. Psychology Health, 14, 1077-1088.
100. Sigurdardottir, V., Bolund, C., & Sullivan, M. (1996). Quality of life evaluation by the EORTC questionnaire technique in patients with generalized malignant melanoma on chemotherapy. Acta Oncoloâgica, 35(2), 149-158.
101. Soong, S. J., Harrison, R. A., McCarthy, W. H., Urist, M. M., & Balch, C. M. (1998). Factors affecting survival following local, regional, or distant recurrence from localized melanoma. Journal of Surgical Oncology, 67(4), 228-233.
102. Soong, S. J., Shaw, H. M., Balch, C. M., McCarthy, W. H., Urist, M. M., & Lee, J. Y. (1992). Predicting survival and recurrence in localized melanoma: A multivariate approach. World Journal of Surgery, 16(2), 191-195.
103. Spiegel, D., Bloom, J. R., Kraemer, H. C., & Gottheil, E. (1989). Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet, 2(8668), 888-891.
104. Stavraky, K. M., Donner, A. P., Kincade, J. E., & Stewart, M. A. (1988). The effect of psychosocial factors on lung cancer mortality at one year. Journal of Clinical Epidemiology, 41(1), 75-82.
105. Surveillance, Epidemiology, and End Results (SEER) Program (2003). SEERStat Database: Incidence - SEER 9 Regulations. Bethesda, Maryland: National Cancer Institute, Division of Cancer Control and Population Sciences. Available at http://www.seer.cancer.gov.
106. Theobald, T., Marks, R., Hill, D., & Dorevitch, A. (1991). "Goodbye sunshine": Effects of a television program about melanoma on beliefs, behavior, and melanoma thickness. Journal of the American Academy of Dermatology, 25(4), 717-723.
107. Trask, P. C., Paterson, A. G., Esper, P., Pau, J., & Redman, B. (2004). Longitudinal course of depression, fatigue, and quality of life in patients with high risk melanoma receiving adjuvant interferon. Psychooncology, 13(8), 526-536.
108. Trask, P. C., Paterson, A. G., Hayasaka, S., Dunn, R. L., Riba, M., & Johnson, T. (2001). Psychosocial characteristics of individuals with non-stage IV melanoma. Journal of Clinical Oncology, 19(11), 2844-2850.
109. Tsao, H., Rogers, G. S., & Sober, A. J. (1998). An estimate of the annual direct cost of treating cutaneous melanoma. Journal of the American Academy of Dermatology, 38(5 Pt 1), 669-680.
110. Tucker, M. A., Fraser, M. C., Goldstein, A. M., Elder, D. E., Guerry, D. T., & Organic, S. M. (1993). Risk of melanoma and other cancers in melanoma-prone families. Journal of Investigative Dermatology, 100(3), 350S-355S.
111. Weinstein, N. D. (1984). Why it won't happen to me: Perceptions of risk factors and susceptibility. Health Psychology, 3(5), 431-457.
112. Weinstein, N. D. (1987). Unrealistic optimism about susceptibility to health problems: Conclusions from a community-wide sample. Journal of Behavioral Medicine, 10(5), 481-500.
113. Weinstock, M. A. (2000). Early detection of melanoma. Journal of the American Medical Association, 284(7), 886-889.